Abrdn Healthcare Investors (NYSE:HQH - Get Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 69,900 shares, a growth of 25.3% from the November 30th total of 55,800 shares. Based on an average daily volume of 181,600 shares, the days-to-cover ratio is currently 0.4 days.
Abrdn Healthcare Investors Price Performance
Shares of NYSE HQH traded down $0.14 during midday trading on Tuesday, hitting $16.05. 614,889 shares of the company's stock were exchanged, compared to its average volume of 228,195. The firm's fifty day simple moving average is $17.47 and its 200-day simple moving average is $18.10. Abrdn Healthcare Investors has a twelve month low of $15.76 and a twelve month high of $19.79.
Abrdn Healthcare Investors Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Thursday, November 21st will be paid a dividend of $0.62 per share. This represents a $2.48 dividend on an annualized basis and a yield of 15.45%. The ex-dividend date is Thursday, November 21st. This is an increase from Abrdn Healthcare Investors's previous quarterly dividend of $0.59.
Institutional Investors Weigh In On Abrdn Healthcare Investors
Large investors have recently modified their holdings of the company. Penserra Capital Management LLC purchased a new stake in shares of Abrdn Healthcare Investors during the third quarter worth approximately $16,145,000. Raymond James & Associates increased its stake in Abrdn Healthcare Investors by 79.8% in the 3rd quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider's stock valued at $6,614,000 after buying an additional 157,618 shares during the period. Needham Investment Management LLC raised its position in Abrdn Healthcare Investors by 3.1% during the 3rd quarter. Needham Investment Management LLC now owns 255,078 shares of the financial services provider's stock worth $4,750,000 after buying an additional 7,729 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in shares of Abrdn Healthcare Investors by 36.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 177,820 shares of the financial services provider's stock worth $3,311,000 after acquiring an additional 47,518 shares during the period. Finally, B. Riley Wealth Advisors Inc. boosted its holdings in shares of Abrdn Healthcare Investors by 28.0% in the second quarter. B. Riley Wealth Advisors Inc. now owns 90,160 shares of the financial services provider's stock valued at $1,576,000 after acquiring an additional 19,719 shares in the last quarter. 32.60% of the stock is owned by institutional investors and hedge funds.
About Abrdn Healthcare Investors
(
Get Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Recommended Stories
Before you consider Abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.
While Abrdn Healthcare Investors currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
